Daymark Wealth Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.42M Sell
18,109
-35,341
-66% -$2.85M 0.03% 294
2026
Q1
$4.63M Buy
53,450
+1,146
+2% +$110K 0.15% 124
2025
Q4
$5.02M Buy
52,304
+146
+0.3% +$14.2K 0.16% 111
2025
Q3
$4.97M Buy
52,158
+3,891
+8% +$358K 0.17% 111
2025
Q2
$4.21M Buy
48,267
+2,009
+4% +$170K 0.16% 115
2025
Q1
$4.16M Buy
46,258
+3,221
+7% +$288K 0.18% 108
2024
Q4
$3.44M Buy
43,037
+484
+1% +$41.9K 0.15% 118
2024
Q3
$3.83M Buy
42,553
+987
+2% +$83K 0.16% 116
2024
Q2
$3.27M Buy
41,566
+8,727
+27% +$715K 0.15% 119
2024
Q1
$2.86M Sell
32,839
-4,258
-11% -$363K 0.15% 105
2023
Q4
$3.06M Sell
37,097
-5,751
-13% -$438K 0.19% 97
2023
Q3
$3.36M Buy
42,848
+3,883
+10% +$325K 0.23% 92
2023
Q2
$3.43M Buy
38,965
+173
+0.4% +$14.9K 0.25% 88
2023
Q1
$3.13M Buy
38,792
+5,559
+17% +$453K 0.41% 57
2022
Q4
$2.58M Buy
+33,233
New +$2.69M 0.46% 50

Other funds holding MDT

Daymark Wealth Partners's MDT Position: Q2 2026 in Review

Daymark Wealth Partners reduced its Medtronic (MDT) stake by 66% in Q2 2026, selling an estimated $2.85M and leaving 18,109 shares worth $1.42M. The position accounts for 0.03% of the portfolio, ranked #294.

Daymark Wealth Partners first reported a position in MDT in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.02M in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Daymark Wealth Partners held 18,109 shares of Medtronic worth $1.42M as of Q2 2026.
  • Daymark Wealth Partners sold 35,341 Medtronic shares in Q2 2026, an estimated $2.85M.
  • Medtronic made up 0.03% of Daymark Wealth Partners's portfolio in Q2 2026, its #294 holding.
  • Daymark Wealth Partners first reported a position in Medtronic in Q4 2022 and has held it in 15 quarters since.
  • Daymark Wealth Partners's Medtronic position peaked at $5.02M in Q4 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Daymark Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.